Eyenovia Inc (EYEN)
0.1019
-0.24
(-70.04%)
USD |
NASDAQ |
Nov 15, 16:00
0.102
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Enterprise Value: 19.61M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 19.61M |
| November 14, 2024 | 37.93M |
| November 13, 2024 | 43.12M |
| November 12, 2024 | 50.64M |
| November 11, 2024 | 47.48M |
| November 08, 2024 | 49.39M |
| November 07, 2024 | 49.20M |
| November 06, 2024 | 50.25M |
| November 05, 2024 | 50.83M |
| November 04, 2024 | 51.62M |
| November 01, 2024 | 50.92M |
| October 31, 2024 | 49.49M |
| October 30, 2024 | 52.46M |
| October 29, 2024 | 54.31M |
| October 28, 2024 | 54.08M |
| October 25, 2024 | 53.25M |
| October 24, 2024 | 51.55M |
| October 23, 2024 | 52.83M |
| October 22, 2024 | 53.53M |
| October 21, 2024 | 54.46M |
| October 18, 2024 | 55.75M |
| October 17, 2024 | 50.85M |
| October 16, 2024 | 54.08M |
| October 15, 2024 | 46.40M |
| October 14, 2024 | 46.91M |
| Date | Value |
|---|---|
| October 11, 2024 | 46.11M |
| October 10, 2024 | 45.77M |
| October 09, 2024 | 46.39M |
| October 08, 2024 | 46.49M |
| October 07, 2024 | 47.69M |
| October 04, 2024 | 48.90M |
| October 03, 2024 | 48.00M |
| October 02, 2024 | 48.92M |
| October 01, 2024 | 50.59M |
| September 30, 2024 | 51.51M |
| September 27, 2024 | 49.85M |
| September 26, 2024 | 47.39M |
| September 25, 2024 | 47.63M |
| September 24, 2024 | 46.62M |
| September 23, 2024 | 46.99M |
| September 20, 2024 | 50.27M |
| September 19, 2024 | 50.27M |
| September 18, 2024 | 50.23M |
| September 17, 2024 | 50.85M |
| September 16, 2024 | 52.87M |
| September 13, 2024 | 53.05M |
| September 12, 2024 | 53.47M |
| September 11, 2024 | 55.08M |
| September 10, 2024 | 56.78M |
| September 09, 2024 | 55.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.12M
Minimum
Mar 18 2020
209.38M
Maximum
May 03 2023
75.33M
Average
68.52M
Median
Jul 24 2020
Enterprise Value Benchmarks
| TFF Pharmaceuticals Inc | -3.084M |
| Reviva Pharmaceuticals Holdings Inc | 31.26M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
| iBio Inc | 6.468M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.05M |
| Revenue (Quarterly) | 0.0226M |
| Total Expenses (Quarterly) | 11.71M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | -2.07K% |
| Profit Margin (Quarterly) | -48.86K% |
| Earnings Yield | -765.5% |
| Normalized Earnings Yield | -784.21 |